Results 251 to 260 of about 66,826 (280)

Adalimumab

Reactions Weekly, 2014
  +6 more sources

Adalimumab

Reactions Weekly, 2023
  +4 more sources

HUMIRA (adalimumab)

SKINmed: Dermatology for the Clinician, 2004
William, Abramovits, Aditya K, Gupta
openaire   +2 more sources

Adalimumab

Reactions Weekly, 2008
  +4 more sources

Adalimumab

Reactions Weekly, 2017
  +4 more sources

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

New England Journal of Medicine, 2021
Marina Magrey, Joseph F Merola, Kishimoto Mitsumasa   +2 more
exaly  

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Lancet, The, 2022
Bruce E Sands, Peter M Irving, Jakob Begun   +2 more
exaly  

Bimekizumab versus Adalimumab in Plaque Psoriasis

New England Journal of Medicine, 2021
Richard B Warren, Andrew Blauvelt, Ka Papp   +2 more
exaly  

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

Lancet, The, 2020
Frank Behrens, Arthur Kavanaugh, Christopher T Ritchlin   +2 more
exaly  

Adalimumab

Reactions Weekly, 2015
openaire   +2 more sources